BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jin N, George TL, Otterson GA, Verschraegen C, Wen H, Carbone D, Herman J, Bertino EM, He K. Advances in epigenetic therapeutics with focus on solid tumors. Clin Epigenetics 2021;13:83. [PMID: 33879235 DOI: 10.1186/s13148-021-01069-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Bajbouj K, Al-Ali A, Ramakrishnan RK, Saber-Ayad M, Hamid Q. Histone Modification in NSCLC: Molecular Mechanisms and Therapeutic Targets. Int J Mol Sci 2021;22:11701. [PMID: 34769131 DOI: 10.3390/ijms222111701] [Reference Citation Analysis]
2 Jiang H, Ge R, Chen S, Huang L, Mao J, Sheng L. miRNA-204-5p acts as tumor suppressor to influence the invasion and migration of astrocytoma by targeting ezrin and is downregulated by DNA methylation. Bioengineered 2021;12:9301-12. [PMID: 34723710 DOI: 10.1080/21655979.2021.2000244] [Reference Citation Analysis]
3 Honoré N, Galot R, van Marcke C, Limaye N, Machiels JP. Liquid Biopsy to Detect Minimal Residual Disease: Methodology and Impact. Cancers (Basel) 2021;13:5364. [PMID: 34771526 DOI: 10.3390/cancers13215364] [Reference Citation Analysis]
4 Han J, Wang DY, Wang Q, Meng L, Luo Z, Li J, Kang Y, Lv W, Huang Q, Wang PG, Wang Y, Shen J, Wang Y. PEGylated Poly-HDACi: A Designer Polyprodrug from Optimized Drug Units. Chemistry 2021. [PMID: 34820923 DOI: 10.1002/chem.202103114] [Reference Citation Analysis]
5 Dobre EG, Constantin C, Costache M, Neagu M. Interrogating Epigenome toward Personalized Approach in Cutaneous Melanoma. J Pers Med 2021;11:901. [PMID: 34575678 DOI: 10.3390/jpm11090901] [Reference Citation Analysis]
6 Cabral LKD, Reyes PAC, Crocè LS, Tiribelli C, Sukowati CHC. The Relevance of SOCS1 Methylation and Epigenetic Therapy in Diverse Cell Populations of Hepatocellular Carcinoma. Diagnostics (Basel) 2021;11:1825. [PMID: 34679523 DOI: 10.3390/diagnostics11101825] [Reference Citation Analysis]
7 Lin HY, Wu HJ, Chen SY, Hou MF, Lin CS, Chu PY. Epigenetic therapy combination of UNC0638 and CI-994 suppresses breast cancer via epigenetic remodeling of BIRC5 and GADD45A. Biomed Pharmacother 2021;145:112431. [PMID: 34798471 DOI: 10.1016/j.biopha.2021.112431] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Cortese R. Epigenetics of Sleep Disorders: An Emerging Field in Diagnosis and Therapeutics. Diagnostics (Basel) 2021;11:851. [PMID: 34068472 DOI: 10.3390/diagnostics11050851] [Reference Citation Analysis]
9 Song M, Cui M, Liu K. Therapeutic strategies to overcome cisplatin resistance in ovarian cancer. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114205] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
10 Zhang X, Wang X, Wu T, Yin W, Yan J, Sun Y, Zhao D. Therapeutic potential of targeting LSD1/ KDM1A in cancers. Pharmacol Res 2021;:105958. [PMID: 34718134 DOI: 10.1016/j.phrs.2021.105958] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Maubach G, Vieth M, Boccellato F, Naumann M. Helicobacter pylori-induced NF-κB: trailblazer for gastric pathophysiology. Trends Mol Med 2022:S1471-4914(21)00322-1. [PMID: 35012886 DOI: 10.1016/j.molmed.2021.12.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]